Biomm S.A.
BIOM3
Rank in Stocks
#18068
Biomm S.A. is a biotechnology enterprise based in Brazil. Its diverse product... Biomm S.A. is a biotechnology enterprise based in Brazil. Its diverse product portfolio features pharmaceutical and healthcare solutions, including AFREZZA, a human insulin administered as an inhalation powder, and GLARGILIN, a type of glargine insulin. The company also supplies HERZUMA, a trastuzumab, and CONFORT CARE, a moisturizing foot cream. Biomm S.A. was established in 2001 and maintains its headquarters in SΓ£o Paulo, Brazil.
Share Price
$1.06
Last synced: 2026-11-10
Market Cap
$145.55M
Change (1 day)
0.00%
Change (1 year)
-22.99%
Country
Stock data: Financial Modeling PrepΒ·Updated Β·Not investment adviceΒ·How we calculate this
Trade Biomm S.A. (BIOM3)
Category
Healthcare
Operating Margin for Biomm S.A. (BIOM3)
Operating Margin as of November 2026 TTM: 13.81%
According to Biomm S.A.'s latest financial reports, its current operating margin (TTM) is 13.81%. At the end of 2025 the company had an operating margin of 1.79%.
Operating Margin history for Biomm S.A. from 2004 to 2026
Operating Margin at the end of each year
| Year | Operating Margin | Change |
|---|---|---|
| 2026 (TTM) | 13.81% | 671.51% |
| 2025 | 1.79% | -103.15% |
| 2024 | -56.83% | -7.38% |
| 2023 | -61.36% | -25.33% |
| 2022 | -82.17% | 34.05% |
| 2021 | -61.30% | -35.13% |
| 2020 | -94.49% | -83.94% |
| 2019 | -588.22% | -74.88% |
| 2018 | -2,341.89% | -93.19% |
| 2017 | -34,389.32% | 0.00% |
| 2016 | 0.00% | 0.00% |
| 2015 | 0.00% | 0.00% |
| 2014 | 0.00% | 0.00% |
| 2013 | 0.00% | 0.00% |
| 2012 | 0.00% | -100.00% |
| 2011 | -1,784.85% | 269.01% |
| 2010 | -483.69% | -16.22% |
| 2009 | -577.30% | 256.91% |
| 2008 | -161.75% | -35.08% |
| 2007 | -249.17% | -6,622.77% |
| 2006 | 3.82% | -102.95% |
| 2005 | -129.41% | 0.00% |
| 2004 | 0.00% | 0.00% |
Operating Margin for similar companies or competitors
| Company | Operating Margin | Operating Margin Difference | Country |
|---|---|---|---|
| 38.59% | -97.21% |
US
|
|
| -149.01% | -110.79% |
US
|
|
| 25.57% | -98.15% |
AU
|
|
| 31.23% | -97.74% |
BE
|
|
| 29.35% | -97.87% |
NL
|
What is a company's Operating Margin?
The operating margin is a key indicator to assess the profitability of a company. Higher operating margins are generaly better as they show that a company is able to sell its products or services for much more than their production costs. The operating margin is calculated by dividing a company's earnings by its revenue.
Questions about Biomm S.A.'s operating margin
What is Biomm S.A.'s operating margin?
Biomm S.A.'s operating margin is 13.81%, as of Nov 2026.
What was Biomm S.A.'s operating margin in 2025?
In 2025, Biomm S.A.'s operating margin was 1.79%, compared with -56.83% in 2024.
How has Biomm S.A.'s operating margin changed since 2020?
From 2020 to 2025, Biomm S.A.'s operating margin was highest in 2025 (1.79%) and lowest in 2020 (-94.49%).
How does Biomm S.A.'s operating margin compare with similar companies?
Biomm S.A.'s operating margin (13.81%) is higher than that of 1 of the 5 similar companies listed above. The highest among them is Vertex Pharmaceuticals Incorporated, with 38.59%.